High materiality7/10
Rhythm Pharmaceuticals (RYTM) PT Raised to $130 at H.C. Wainwright
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright raises Rhythm Pharmaceuticals target to $130; current price $90.78.
- Target $130; price $90.78; H.C. Wainwright.
Key facts
- 01
Target: $130
- 02
Posted price: $90.78
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Raghuram Selvaraju
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.